Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Elotuzumab

EU orphan designation number: EU/3/12/1037   
Active ingredient: Elotuzumab
Indication: Treatment of multiple myeloma
Sponsor: Bristol-Myers Squibb Pharma EEIG
Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/08/2012 Orphan designation EMA/OD/061/12 (2012)5800 of 09/08/2012